MedPath
TGA Approval

IRBESARTAN HCT MYLAN 150/12.5 irbesartan/hydrochlorothiazide 150/12.5 mg tablet bottle (215943)

215943

IRBESARTAN HCT MYLAN 150/12.5 irbesartan/hydrochlorothiazide 150/12.5 mg tablet bottle

Alphapharm Pty Ltd

November 29, 2013

Medicine

Medicine

Active

Registered

Active Ingredients

hydrochlorothiazide

irbesartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IRBESARTAN HCT MYLAN 150/12.5 irbesartan/hydrochlorothiazide 150/12.5 mg tablet bottle (215943) - TGA 批准文号 | MedPath